Sawai’s New Kanto Factory Complete, Production To Start In March
This article was originally published in PharmAsia News
Executive Summary
Sawai Pharmaceuticals’ new ¥10 billion oral solid drug manufacturing plant in Chiba prefecture’s Mobara City will begin production later this month.